Vaginal estrogen after 50: Can it really lower UTI and sepsis risk?

Vaginal estrogen is gaining attention after the FDA began removing broad black-box warnings on menopausal hormone therapy. But can local estrogen really help prevent recurrent UTIs and serious infections after menopause?Vaginal estrogen is often associated with dryness and painful sex, but doctors also recommend it for recurrent UTIs after menopause. Here is what the latest evidence says. (Representative Image: Pexels)A post by physician Robin Berzin, MD, has brought renewed attention to vaginal estrogen and its possible benefits for women after menopause. Berzin says women over 50 should consider vaginal estrogen even before symptoms become severe, pointing to its role in maintaining vaginal and urinary tissues and preventing recurrent urinary tract infections (UTIs).But the claim needs some context. Vaginal estrogen is not something every woman over 50 should automatically start. Medical guidelines recommend it particularly for peri- and postmenopausal women with recurrent UTIs when there is no contraindication.WHY VAGINAL ESTROGEN IS BEING DISCUSSEDAfter menopause, falling oestrogen levels can cause changes in the vaginal and urinary tissues. This can lead to dryness, irritation, painful sex and an increased risk of recurrent UTIs. Low-dose vaginal estrogen is applied locally through products such as creams, tablets, inserts or rings. Because it is used locally, systemic absorption is low.Berzin says vaginal estrogen is often misunderstood as a treatment only for dryness or painful sex. She argues that maintaining vaginal and urinary tissues can also help protect against infections.WHAT HAPPENED TO THE FDA BLACK-BOX WARNING? In November 2025, the US FDA began removing broad boxed warnings from menopausal hormone therapy products, including topical vaginal estrogen. The warnings had been introduced after concerns arising from the Women's Health Initiative and had subsequently been applied broadly to different forms of hormone therapy.The US FDA said the labelling changes were intended to give women and doctors more accurate information about the benefits and risks of these medicines. However, this does not mean hormone therapy is risk-free or that everyone should use it.CAN VAGINAL ESTROGEN LOWER SEPSIS AND DEATH RISK?This is one of the strongest claims in Berzin’s post.A 2025 study published in The Journal of Urology examined more than two million women with recurrent UTIs. Among women over 55, those using vaginal estrogen had lower rates of hospitalisation, sepsis and death than those who were not using it.Death occurred in 0.42 per cent of estrogen users compared with 1.54 per cent of non-users, equivalent to a 73 per cent lower odds of death in the study.Screengrab of her postBut this was a retrospective observational study, not a randomised clinical trial. So the findings show an association and do not prove that vaginal estrogen itself prevented these deaths.SHOULD WOMEN OVER 50 START IT?Not automatically.Vaginal estrogen can be an effective option for women experiencing genitourinary symptoms of menopause and is specifically recommended for preventing recurrent UTIs in appropriate postmenopausal women. The right product and dose depend on the individual.Women with a history of breast cancer or other medical concerns should discuss vaginal estrogen with their doctor before using it. It should be treated as a medical decision, not a routine supplement for everyone over 50.- EndsPublished By: vaishnavi parasharPublished On: Aug 25, 2026 17:50 IST